Gösterilen 1 - 6 sonuçlar arası kayıtlar. 6 sonuç. Aranan kelime 'Flynt, E', Sorgu süresi: 0.02s Sonuçları Daraltın
  1. 1
    Reading iventory : for the classroom /

    Reading iventory : for the classroom / Yazar: 449570 Flynt, E. Sutton, Cooter, Robert B.

    Baskı/Yayın Bilgisi 1998
  2. 2
    Pharmacodynamic changes in tumor and immune cells drive iberdomide's clinical mechanisms of activity in relapsed and refractory multiple myeloma

    Pharmacodynamic changes in tumor and immune cells drive iberdomide's clinical mechanisms of activity in relapsed and refractory multiple myeloma Yazar: Amatangelo, M, Flynt, E, Stong, N, Ray, P, Van Oekelen, O, Wang, M, Ortiz, M, Maciag, P, Peluso, T, Parekh, S, van de Donk, NWCJ, Lonial, S, Thakurta, A

    Baskı/Yayın Bilgisi 2024
    Journal article
  3. 3
    Loss of COP9 signalosome gene-containing 2q region is associated with lenalidomide and pomalidomide resistance in myeloma patients

    Loss of COP9 signalosome gene-containing 2q region is associated with lenalidomide and pomalidomide resistance in myeloma patients Yazar: Gooding, S, Ansari-Pour, N, Kazeroun, MH, Karagoz, K, Salazar, MA, Fitzsimons, E, Estevez, MO, Towfic, F, Flynt, E, Pierceall, WE, Yong, K, Vyas, P, Thakurta, A

    Baskı/Yayın Bilgisi 2021
    Conference item
  4. 4
    Multiple cereblon genetic changes are associated with acquired resistance to lenalidomide or pomalidomide in multiple myeloma

    Multiple cereblon genetic changes are associated with acquired resistance to lenalidomide or pomalidomide in multiple myeloma Yazar: Gooding, S, Ansari-Pour, N, Towfic, F, Ortiz Estévez, M, Chamberlain, PP, Tsai, K-T, Flynt, E, Hirst, M, Rozelle, D, Dhiman, P, Neri, P, Ramasamy, K, Bahlis, N, Vyas, P, Thakurta, A

    Baskı/Yayın Bilgisi 2020
    Journal article
  5. 5
    Iberdomide increases innate and adaptive immune cell subsets in the bone marrow of patients with relapsed/refractory multiple myeloma

    Iberdomide increases innate and adaptive immune cell subsets in the bone marrow of patients with relapsed/refractory multiple myeloma Yazar: Van Oekelen, O, Amatangelo, M, Guo, M, Upadhyaya, B, Cribbs, AP, Kelly, G, Patel, M, Kim-Schulze, S, Flynt, E, Lagana, A, Gooding, S, Merad, M, Jagganath, S, Pierceall, WE, Oppermann, U, Thakurta, A, Parekh, S

    Baskı/Yayın Bilgisi 2024
    Journal article
  6. 6
    Loss Of COP9-signalosome genes Aa 2q37 is associated with IMiD agent resistance in multiple myeloma

    Loss Of COP9-signalosome genes Aa 2q37 is associated with IMiD agent resistance in multiple myeloma Yazar: Gooding, S, Ansari-Pour, N, Kazeroun, MH, Karagoz, K, Polonskaia, A, Angulo Salazar, M, Fitzsimons, E, Sirinukunwattana, K, Chavda, SJ, Ortiz Estevez, M, Towfic, F, Flynt, E, Pierceall, W, Royston, D, Yong, KL, Ramasamy, K, Vyas, P, Thakurta, A

    Baskı/Yayın Bilgisi 2022
    Journal article

Arama Araçları: